Evidence map›Paper›PMID 40465398›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2025

The Patient-reported Longitudinal Assessment Tool for OSA (PLATO): development and validation of a new clinical tool to assess response to obstructive sleep apnea treatment in adults.

Douglas Kirsch, Fariha Abbasi-Feinberg, Charles Davies, Charlene Gamaldo, Sherene Thomas, Patricia Koochaki, Christiane Otto, Kelly Lipman, Carol L Rosen

Registry-linked trialAbstract readValidation Study
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07789834 (Application of the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07789834 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Application of the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea

TypeobservationalSponsorNevada Dental SleepRan2026 to 2027Enrolled20ConditionsObstructive Sleep Apnea (OSA), Oral Applliance TherapyArmsThe study will assess the feasibility of incorporating the PLATO questionnaire into a dental sleep practice. The PLATO questionnaire was developed as a patient reported outcome measure
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Sleep apnea, how do we help thee? Let us count the ways.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Douglas KirschAtrium Health, Charlotte, North Carolina.
Fariha Abbasi-FeinbergMillennium Physician Group, Fort Myers, Florida.
Charles DaviesCarle Neuroscience Institute, Carle Health, Urbana, Illinois.
Charlene GamaldoJohns Hopkins School of Medicine, Baltimore, Maryland.
Sherene ThomasAmerican Academy of Sleep Medicine, Darien, Illinois.
Patricia KoochakiICON plc, Blue Bell, Pennsylvania.
Christiane OttoICON plc, Frankfurt, Germany.
Kelly LipmanICON plc, Blue Bell, Pennsylvania.
Carol L RosenCase Western Reserve University School of Medicine, Cleveland, Ohio.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesTo develop and validate a publicly available, patient-reported outcome (PRO) tool specific to obstructive sleep apnea (OSA) in adults, designed for clinical use to monitor treatment response and longitudinal symptom progression.

methodsThe PRO tool was developed in accordance with Food and Drug Administration guidance for PRO measures, utilizing a multiphase, mixed-methods approach. Part 1 involved concept elicitation and cognitive interviews with patients to identify key symptoms and impacts. Part 2 consisted of pilot testing the draft tool in 10 American Academy of Sleep Medicine-accredited sleep centers. Part 3 included psychometric validation using longitudinal online surveys in 560 adults with OSA and 40 controls. Analyses included exploratory factor analysis, Rasch modeling, test-retest reliability, internal consistency, construct validity, responsiveness to change, and determination of clinically important difference thresholds.

resultsThe final 11-item Patient-reported Longitudinal Assessment Tool for OSA has a 7-day recall period and assesses both daytime and nighttime OSA symptoms. It demonstrated strong internal consistency (α = 0.94), test-retest reliability (intraclass correlation coefficients = 0.91-0.97), and construct validity through moderate to strong correlations with established measures. The 11-item Patient-reported Longitudinal Assessment Tool for OSA scores discriminated between OSA severity and body mass index groups and were responsive to symptom improvement. The mean completion time was under 4 minutes. The tool can be used in both paper and electronic formats and has been translated into Spanish.

conclusionsThe 11-item Patient-reported Longitudinal Assessment Tool for OSA is a valid, reliable, and feasible PRO instrument for assessing OSA-related symptoms in clinical practice. It enables efficient monitoring of PROs across treatment stages. CITATION: Kirsch D, Abbasi-Feinberg F, Davies C, et al. The Patient-reported Longitudinal Assessment Tool for OSA (PLATO): development and validation of a new clinical tool to assess response to obstructive sleep apnea treatment in adults.

Indexed as

Patient Reported Outcome MeasuresSleep Apnea, ObstructiveAdultAgedFemaleHumansLongitudinal StudiesMaleMiddle AgedPsychometricsReproducibility of ResultsSurveys and Questionnairesobstructive sleep apneapatient-reported outcomesPLATO-11psychometric validationsleep medicinetreatment monitoring

Identifiers

PMID40465398
PMCPMC12493073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.